Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes (Aim 2 Study)
Overview
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Enrollment
- 2,000
- Locations
- 1
- Primary Endpoint
- Harm perception - One time use
Overview
Brief Summary
This study looks at how cannabis product label and marketing claims affect product perceptions, use expectancies, and use intentions among inexperienced and experienced cannabis users. Participants will answer online survey questions on their perceptions of a cannabis product advertisement.
Detailed Description
This study aims to specify how product label and marketing claims affect product perceptions, use expectancies, and use intentions among cannabis users. A randomized 4 (Sativa, Indica, Hybrid, no strain label) x 3 (energizing, sedative, no claim) online experiment will be conducted with a sample of adults from states that have legalized adult cannabis recreational use. Our main research questions are: (1) Do label and marketing claim affect (a) harm perceptions, (b) subjective effects expectancies (e.g., arousal, sedation), (c) willingness to use, and (d) willingness to use during daily activities (e.g., driving)? and (2) Do label and marketing claim interact to affect product perceptions, use expectancies, and use intentions?
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Factorial
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 21 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Age = 21+
- •Live in in a US state (or Washington D.C.) in which recreational cannabis sale is legal and implemented
- •For inexperienced users: lifetime cannabis use \>1 \& \<= 10
- •For experienced users: lifetime cannabis use\>10 \& \<100, past month cannabis use\>0
Exclusion Criteria
- •Under age 21
- •Does not live in a US state (or Washington D.C.) in which recreational cannabis sale is legal and implemented
- •Lifetime cannabis use \>=100 times
- •Lifetime cannabis use \<1 time
- •Lifetime cannabis use\>10 \& \<100 AND past month cannabis use=0
Arms & Interventions
Hybrid/Energizing
Ad features Hybrid label + energizing claim
Intervention: Strain label (Other)
Sativa/Sedating
Ad features Sativa label + sedating claim
Intervention: Claim (Other)
Sativa/No claim
Ad features Sativa label + no claim
Intervention: Strain label (Other)
Indica/Energizing
Ad features Indica label + energizing claim
Intervention: Strain label (Other)
Indica/Energizing
Ad features Indica label + energizing claim
Intervention: Claim (Other)
Indica/Sedating
Ad features Indica label + sedating claim
Intervention: Strain label (Other)
Indica/Sedating
Ad features Indica label + sedating claim
Intervention: Claim (Other)
Indica/No claim
Ad features Indica label + no claim
Intervention: Strain label (Other)
Sativa/Energizing
Ad features Sativa label + energizing claim
Intervention: Strain label (Other)
Sativa/Energizing
Ad features Sativa label + energizing claim
Intervention: Claim (Other)
Sativa/Sedating
Ad features Sativa label + sedating claim
Intervention: Strain label (Other)
Hybrid/Energizing
Ad features Hybrid label + energizing claim
Intervention: Claim (Other)
Hybrid/Sedating
Ad features Hybrid label + sedating claim
Intervention: Strain label (Other)
Hybrid/Sedating
Ad features Hybrid label + sedating claim
Intervention: Claim (Other)
Hybrid/No claim
Ad features Hybrid label + no claim
Intervention: Strain label (Other)
No strain/Energizing
Ad features no strain label + energizing claim
Intervention: Claim (Other)
No strain/Sedating
Ad features no strain label + sedating claim
Intervention: Claim (Other)
No strain/No claim
Ad features no strain label + no claim
Outcomes
Primary Outcomes
Harm perception - One time use
Time Frame: Immediately after viewing ad
How harmful participant perceives the product to be after one time use. Participants will answer a survey item, In your opinion, what is the level of risk to one's health from using the product you just viewed one time?; with response options ranging from 0-Very low risk to 4-Very high risk.
Harm perception - Daily use
Time Frame: Immediately after viewing ad
How harmful participant perceives the product to be with daily use. Participants will answer a survey item, In your opinion, what is the level of health risk from using the product you just viewed on a daily basis?; with response options ranging from 0-Very low risk to 4-Very high risk.
Expectancy effects
Time Frame: Immediately after viewing ad
Effects participant expects to feel after using the product. Participants will answer a survey item, Please rate the extent to which you expect to feel each of the following effects \[paranoid; panicked; fearful; anxious; suspicious; like my heart is racing; sluggish; drowsy; out of it; slow; lazy; excited; heightened senses; sociable; creative; wise; in tune with nature; focused; productive; sleepy; happy; euphoric; calm; relaxed; pain-free\] after using the product you just viewed; with response options ranging from 0-not at all to 10-extremely.
Willingness to use
Time Frame: Immediately after viewing ad
How willing participant is to use the product. Participants will answer a survey item, How willing would you be to use the product you just viewed?; with response options ranging from 0-Not at all willing to 4-Very willing.
Willingness to use during daily activities
Time Frame: Immediately after viewing ad
How willing participant is to use the product during daily activities. Participants will answer a survey item, How willing would you be to use the product you just viewed if you \[wanted to concentrate; wanted to relax; wanted to socialize; wanted to do a creative activity (e.g., art, music); wanted to feel happier; wanted to relieve medical symptoms/treat a medical condition/mental health condition; were going to drive a car in the next 30 minutes; were going to bed in the next 30 minutes; were planning to stay home for the next several hours; were going to work in the next 30 minutes; were at a party\]?; with response options ranging from 0-Not at all willing to 4-Very willing.
Secondary Outcomes
No secondary outcomes reported